相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
Linda Villard et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
First-Line Chemotherapy With Capecitabine and Temozolomide in Patients With Metastatic Pancreatic Endocrine Carcinomas
Jonathan R. Strosberg et al.
CANCER (2011)
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy
Giampiero Giovacchini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
Jolanta Kunikowska et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
Stephan Walrand et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Anna Imhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment
Helmut R. Maecke et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
177Lu-DOTATATE Molecular Radiotherapy for Childhood Neuroblastoma
Jennifer E. Gains et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
Tina Binderup et al.
CLINICAL CANCER RESEARCH (2010)
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Dik J. Kwekkeboom et al.
ENDOCRINE-RELATED CANCER (2010)
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
Edgar J. Rolleman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
Mattias Sandstrom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging
Emilio Bombardieri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
Irene Virgolini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
Els L. van Persijn van Meerten et al.
EUROPEAN RADIOLOGY (2010)
90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
David L. Bushnell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors
Yusuf Menda et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer Long-term Results of a Phase 2 Clinical Trial
Fabienne Iten et al.
CANCER (2009)
Effects of therapy with [177Lu-DOTA0,Tyr3]octreotate on endocrine function
Jaap J. M. Teunissen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
Flavio Forrer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma
Mirco Bartolomei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation
Thomas J. Vogl et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Peptide receptor therapies in neuroendocrine tumors
L. Bodei et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Highly Efficient In Vivo Agonist-Induced Internalization of sst(2) Receptors in Somatostatin Target Tissues
Bea Waser et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Follow-Up and Documentation
Rudolf Arnold et al.
NEUROENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations
Anders Sundin et al.
NEUROENDOCRINOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Chemotherapy in Patients with Neuroendocrine Tumors
Barbro Eriksson et al.
NEUROENDOCRINOLOGY (2009)
Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging
D. Minarik et al.
PHYSICS IN MEDICINE AND BIOLOGY (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
Julie King et al.
CANCER (2008)
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE:: the role of associated risk factors
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate
Bart de Keizer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors
Marie-Louise H. Fjaellskog et al.
NEUROENDOCRINOLOGY (2008)
Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases
Paresh P. Kamat et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
Consensus guidelines for the management of patients with liver metastases from digestive (neuro) endocrine tumors: Foregut, midgut, hindgut, and unknown primary
Thomas Steinmueller et al.
NEUROENDOCRINOLOGY (2008)
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: Well-differentiated colon and rectum tumour/carcinoma
John K. Ramage et al.
NEUROENDOCRINOLOGY (2008)
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: Well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma
Ursula Ploeckinger et al.
NEUROENDOCRINOLOGY (2008)
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - Well-differentiated jejunal-ileal tumor/carcinoma
Barbro Eriksson et al.
NEUROENDOCRINOLOGY (2008)
Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer:: A phase II clinical trial
Fabienne Iten et al.
CLINICAL CANCER RESEARCH (2007)
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin
Martijn van Essen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
Emilio Bajetta et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Dosimetry for 90Y-DOTATOC therapies in patients with neuroendocrine tumors
Cecilia Hindorf et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Results of individual patient dosimetry in peptide receptor radionuclide therapy with Lu-177 DOTA-TATE and Lu-177 DOTA-NOC
Christiane Wehrmann et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival
Babak Givi et al.
SURGERY (2006)
Radiation protection in radionuclide therapies with 90Y-conjugates:: risks and safety
Marta Cremonesi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours
M Rodrigues et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors
MH Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Midgut carcinoid tumours:: surgical treatment and prognosis
G Åkerström et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy
D Beutler et al.
CANCER (2005)
Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas
L Bodei et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours
A Helisch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
A comparison of 111In-DOTATOC and 111In-DOTATATE:: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
F Forrer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours
L Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas
MA Kouvaraki et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Rapid and sustained relief from the symptoms of carcinoid syndrome: Results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide
P Ruszniewski et al.
NEUROENDOCRINOLOGY (2004)
A systematic review of the comparative safety of colloids
ME Barron et al.
ARCHIVES OF SURGERY (2004)
86Y-DOTA0-D-Phe1-Tyr3-octreotide (SMT487) -: a phase 1 clinical study:: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion
F Jamar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine
EJ Rolleman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide:: The Rotterdam experience
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours:: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide
GJ Förster et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
[177Lu-DOTA0,Tyr3]octreotate:: comparison with [111In-DTPA0]octreotide in patients
DJ Kwekkeboom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors
P Ruszniewski et al.
DIGESTION (2000)
Interferon in the management of neuroendocrine GEP-tumors - A review
K Oberg
DIGESTION (2000)
分享论文
